ACR-2316 is a potentially first-in-class, мощный, селективный WEE1/PKMYT1 ингибитор с IC50 of 2 nM/44 nM. ACR-2316 demonstrates greater potency in all клетка lines tested compared to adavosertib and lunresertib.
ACR-2316 is a potentially first-in-class, potent, selective WEE1/PKMYT1 inhibitor with IC50 of 2 nM/44 nM. ACR-2316 demonstrates greater potency in all cell lines tested compared to adavosertib and lunresertib.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.